Global Psoriasis Therapeutics Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Psoriasis Therapeutics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 TNF Inhibitors
  • 1.4.3 PDE4 Inhibitors
  • 1.4.4 Interleukin Blockers
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Oral
  • 1.5.3 Parenteral
  • 1.5.4 Topical
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Psoriasis Therapeutics Market Perspective (2015-2026)
• 2.2 Global Psoriasis Therapeutics Growth Trends by Regions
  • 2.2.1 Psoriasis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Psoriasis Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Psoriasis Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Psoriasis Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Psoriasis Therapeutics Players by Market Size
  • 3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Psoriasis Therapeutics Market Concentration Ratio
  • 3.2.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2019
• 3.3 Psoriasis Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Psoriasis Therapeutics Product Solution and Service
• 3.5 Date of Enter into Psoriasis Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Psoriasis Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Psoriasis Therapeutics Market Size (2015-2020)
• 6.2 Psoriasis Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Psoriasis Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Psoriasis Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Psoriasis Therapeutics Market Size (2015-2020)
• 7.2 Psoriasis Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Psoriasis Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Psoriasis Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Psoriasis Therapeutics Market Size (2015-2020)
• 8.2 Psoriasis Therapeutics Key Players in China (2019-2020)
• 8.3 China Psoriasis Therapeutics Market Size by Type (2015-2020)
• 8.4 China Psoriasis Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Psoriasis Therapeutics Market Size (2015-2020)
• 9.2 Psoriasis Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Psoriasis Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Psoriasis Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Psoriasis Therapeutics Market Size (2015-2020)
• 10.2 Psoriasis Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Psoriasis Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Psoriasis Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Psoriasis Therapeutics Market Size (2015-2020)
• 11.2 Psoriasis Therapeutics Key Players in India (2019-2020)
• 11.3 India Psoriasis Therapeutics Market Size by Type (2015-2020)
• 11.4 India Psoriasis Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Psoriasis Therapeutics Market Size (2015-2020)
• 12.2 Psoriasis Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Psoriasis Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Psoriasis Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Astellas Pharma Inc.
  • 13.1.1 Astellas Pharma Inc. Company Details
  • 13.1.2 Astellas Pharma Inc. Business Overview
  • 13.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
  • 13.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2015-2020))
  • 13.1.5 Astellas Pharma Inc. Recent Development
• 13.2 AstraZeneca plc
  • 13.2.1 AstraZeneca plc Company Details
  • 13.2.2 AstraZeneca plc Business Overview
  • 13.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
  • 13.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.2.5 AstraZeneca plc Recent Development
• 13.3 Boehringer Ingelheim GmbH
  • 13.3.1 Boehringer Ingelheim GmbH Company Details
  • 13.3.2 Boehringer Ingelheim GmbH Business Overview
  • 13.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
  • 13.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.3.5 Boehringer Ingelheim GmbH Recent Development
• 13.4 F. Hofffmann-La Roche
  • 13.4.1 F. Hofffmann-La Roche Company Details
  • 13.4.2 F. Hofffmann-La Roche Business Overview
  • 13.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
  • 13.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.4.5 F. Hofffmann-La Roche Recent Development
• 13.5 GlaxoSmithKline plc
  • 13.5.1 GlaxoSmithKline plc Company Details
  • 13.5.2 GlaxoSmithKline plc Business Overview
  • 13.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
  • 13.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.5.5 GlaxoSmithKline plc Recent Development
• 13.6 Merck & Co., Inc.
  • 13.6.1 Merck & Co., Inc. Company Details
  • 13.6.2 Merck & Co., Inc. Business Overview
  • 13.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
  • 13.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.6.5 Merck & Co., Inc. Recent Development
• 13.7 Valeant Pharmaceuticals International, Inc.
  • 13.7.1 Valeant Pharmaceuticals International, Inc. Company Details
  • 13.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
  • 13.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
  • 13.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
• 13.8 Biocon Limited
  • 13.8.1 Biocon Limited Company Details
  • 13.8.2 Biocon Limited Business Overview
  • 13.8.3 Biocon Limited Psoriasis Therapeutics Introduction
  • 13.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.8.5 Biocon Limited Recent Development
• 13.9 Eli Lilly and Company
  • 13.9.1 Eli Lilly and Company Company Details
  • 13.9.2 Eli Lilly and Company Business Overview
  • 13.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
  • 13.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.9.5 Eli Lilly and Company Recent Development
• 13.10 G & W Laboratories Inc.
  • 13.10.1 G & W Laboratories Inc. Company Details
  • 13.10.2 G & W Laboratories Inc. Business Overview
  • 13.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
  • 13.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
  • 13.10.5 G & W Laboratories Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer